Stratified survival analysis of HCC, according to clinical stage, tumor size and serum AFP, evaluated PLK4 expression to be closely correlated with survival of HCC patients with stage III–IV, larger tumor size and high-level AFP. This evidence concerns the gene PLK4 and hepatocellular carcinoma.